RxDoctor Payments Data
★ My doctorsLook up a doctor →

Osama Hlalah

Hematology & Oncology · Gainesville, FLNPI 1144210022

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 52 manufacturers reported payments, led by AMAG Pharmaceuticals, Inc. at 52.2% of the total. Reporting peaked in 2019 at $23,849 and has fallen 99.0% since, to $239 in 2025.

$40,136in general payments, 2019–2025

Across 393 payments — averaging $102.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AMAG Pharmaceuticals, Inc.$21K
  • Johnson & Johnson$5K
  • Bristol Myers Squibb$4K
  • Rigel Pharmaceuticals, Inc.$3K
  • Novartis$2K
  • E.r. Squibb & Sons, L.L.C.$590
  • plus $4K from 46 others
$370,896in research payments, 2019–2025

Across 122 payments — averaging $3040.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$251K
  • Incyte Corporation$53K
  • Helsinn Healthcare SA$26K
  • Amgen$24K
  • Bristol Myers Squibb$7K
  • Spectrum Pharmaceuticals Inc.$5K
  • plus $4K from 1 others

What the payments were for

  • Consulting fees$7,71519%
  • Speaking & faculty fees$21,00052%
  • Travel & lodging$2,7987%
  • Food & beverage$6,75517%
  • Education$3371%
  • Other$1,5314%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AMAG Pharmaceuticals, Inc.24$20,954
Johnson & Johnson(2 entities)28$5,085
Bristol Myers Squibb17$3,826
Rigel Pharmaceuticals, Inc.6$2,992
Novartis58$2,325
E.r. Squibb & Sons, L.L.C.35$590
Astellas Pharma US Inc26$522
Pfizer31$439
Merck18$352
Daiichi Sankyo Inc.15$306
Sanofi9$189
Incyte Corporation9$170
Boehringer Ingelheim7$164
Seagen Inc.4$152
Genentech USA, Inc.8$149
Gilead(2 entities)8$145
Exelixis Inc.7$114
Lilly USA, LLC7$105
Array Biopharma Inc6$105
Amgen6$99
AstraZeneca5$97
Takeda Pharmaceuticals U.S.A., Inc.4$91
Coherus Oncology, Inc.2$91
Jazz Pharmaceuticals Inc.5$88
Eisai Inc.5$88
Global Blood Therapeutics, Inc.4$77
US Oncology Corporate, Inc.1$69
AbbVie3$63
Pharmacyclics LLC, An Abbvie Company2$58
Foundation Medicine, Inc.2$57
Bayer3$56
Karyopharm Therapeutics Inc.3$49
Acceleron Pharma, Inc.3$48
Clovis Oncology, Inc.3$47
Genmab U.S., Inc.1$32
Morphosys, US Inc.2$31
Tersera Therapeutics LLC1$25
Mirati Therapeutics, Inc.1$23
Ipsen Biopharmaceuticals, Inc1$23
Mylan Institutional Inc.1$22
Emmaus Medical, Inc.1$22
Abbott1$22
Partner Therapeutics, Inc.1$20
Taiho Oncology, Inc.1$19
Sobi, Inc1$19
CTI Biopharma Corp.1$19
GSK1$18
Dova Pharmaceuticals1$17
Pharmacosmos Therapeutics Inc.1$17
Myovant Sciences Inc.1$16
Tactile Systems Technology Inc1$15
Verastem, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,136 in reported general payments places this provider in the 80th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Other hematology & oncology in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →